Opendata, web and dolomites

SKIN SUBSTITUTE SIGNED

Development of hybrid artificial skin substitute for chronic diabetic wounds

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SKIN SUBSTITUTE project word cloud

Explore the words cloud of the SKIN SUBSTITUTE project. It provides you a very rough idea of what is the project "SKIN SUBSTITUTE" about.

skin    diabetes    hybrid    bioactive    hmsc    group    components    controls    keratinocyte    2030    complementary    grafts    collaborative    leadership    clinical    professional    network    gold    benefit    malignancies    approved    affairs    24    vitro    fda    dulce    position    therapeutic    translate    cell    rabbit    molecular    antibacterial    completion    biology    requiring    leveraging    functionalized    biopolymer    amputation    medical    commercial    wound    secondment    acting    polymer    fibroblast    agents    million    stereological    3d    alloxan    reimbursement    68    diversity    foot    standards    antimicrobial    evaluation    efficacy    communication    first    patients    culture    ulcer    14    it    model    device    worse    ago    prof    incidence    dfu    alloderm    international    diabetic    regulatory    independence    nanoparticles    exchequer    transferable    histological    incorporating    trial    training    intellectual    plan    discipline    substitute    maturity    reg    garcia    healing    goals    papy    models    combines    career    clinic    mortality    people    motivation    cellular    techniques    establishing    vivo    setting    progress    compatibility    zno    integra    43    15    innovative    validate    strategies    strategy    interventions    me    property    time    scaffold    pandit    skills    synthetic   

Project "SKIN SUBSTITUTE" data sheet

The following table provides information about the project.

Coordinator
NATIONAL UNIVERSITY OF IRELAND GALWAY 

Organization address
address: UNIVERSITY ROAD
city: Galway
postcode: H91
website: www.nuigalway.ie

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Total cost 187˙866 €
 EC max contribution 187˙866 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2020-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NATIONAL UNIVERSITY OF IRELAND GALWAY IE (Galway) coordinator 187˙866.00

Map

 Project objective

It is estimated that the incidence of diabetes in Europe will affect 43 million people by 2030. 15% of diabetic patients develop a diabetic foot ulcer (DFU) with 14-24% of these patients requiring amputation. Mortality following amputation of 50–68% is comparable or worse than for most malignancies. My strategy will develop for the first time a skin substitute which combines a biopolymer and a functionalized synthetic FDA approved polymer incorporating bioactive components and AgO and ZnO nanoparticles as antibacterial agents. The cellular compatibility of the hybrid skin substitute will be assessed on fibroblast, keratinocyte and hMSC in a 3D cell culture model. The antimicrobial efficacy will be assessed in vitro and in vivo. The optimised scaffold will be assessed in an alloxan-induced diabetic rabbit ulcer model with gold standards Integra® and Alloderm® skin grafts acting as commercial controls to validate the commercial potential of the technology. Progress to completion will be reviewed by a Research and Professional Development Plan which will provide both discipline-specific and complementary technical training (molecular biology, diabetic wound healing in vivo models, and histological and stereological techniques) and generic and complementary transferable skills training (e.g. intellectual property, leadership skills, motivation skills, communication skills, leveraging non-exchequer funding, regulatory affairs, clinical trial design, reimbursement strategies, medical device evaluation and regulatory affairs). I will benefit from Prof Pandit’s and Prof Dulce Papy-Garcia (secondment) international collaborative network in the field of diabetic wound healing. This training will facilitate me to achieve my future career goals of achieving a position of professional maturity, diversity and independence by establishing my own research group at a leading European institution and enabling me to translate innovative therapeutic interventions to the clinic setting.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SKIN SUBSTITUTE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SKIN SUBSTITUTE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

MarshFlux (2020)

The effect of future global climate and land-use change on greenhouse gas fluxes and microbial processes in salt marshes

Read More  

LICONAMCO (2019)

Light-controlled nanomagnetic computation schemes

Read More  

CoCoNat (2019)

Coordination in constrained and natural distributed systems

Read More